As the international community of experts in head-and-neck cancers gathered virtually last week to share new ideas and treatment strategies at the just-ended American Head & Neck Society (AHNS) 10th International Conference on Head and Neck Cancer,...
26-Jul-2021 12:30 PM EDT Add to Favorites
Roswell Park Team Shows Dendritic-Cell Vaccines Can Be Paired With Standard Therapy for Breast Cancer
A Roswell Park Comprehensive Cancer Center team reports new data on the promise of combining standard treatment for breast cancer with a particular form of cancer immunotherapy — dendritic-cell (DC) treatment vaccines.
19-Jul-2021 5:05 PM EDT Add to Favorites
Roswell Park Experts Highlight Opportunities to Improve Outcomes for People with Gastroesophageal Cancer
Two Roswell Park Comprehensive Cancer Center experts were invited to present new insights on treatment of gastroesophageal cancers during the European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2021. In their...
2-Jul-2021 2:00 PM EDT Add to Favorites
Even as the COVID-19 pandemic took hold, Roswell Park Comprehensive Cancer Center scientists continued to draw support for their innovative research proposals, garnering more than $34 million in competitive grants from government agencies and...
30-Jun-2021 2:50 PM EDT Add to Favorites
New Insights on Sarcomatoid Kidney Cancer: Roswell Park Reports Clear Benefit from Checkpoint Inhibitors
New collaborative research shows that treatment with immune checkpoint inhibitors (ICIs) has led to a significant improvement in survival and response rates among patients with a particularly aggressive type of kidney cancer: advanced sarcomatoid...
9-Jun-2021 3:05 PM EDT Add to Favorites
Breast Cancer Study: African Americans Not Experiencing Complete Response to Extent Other Groups Are
Researchers at Roswell Park Comprehensive Cancer Center led the largest study to date to suggest an improving trend in pathologic complete response rates over time for U.S. cancer patients of various races. The team's findings, documented in a...
9-Jun-2021 1:05 PM EDT Add to Favorites
Biomarker Uncovered by Roswell Park Team Identifies NET Patients Likely to Have Blood Side Effects from PRRT
New work from a team at Roswell Park Comprehensive Cancer Center will help guide the care of patients with neuroendocrine tumors, or NETs. In a poster presentation at the American Society of Clinical Oncology (ASCO) virtual Annual Meeting 2021,...
9-Jun-2021 12:10 PM EDT Add to Favorites
Roswell Park Team Demonstrates Safe Approach for Dramatically Reducing Use of Opioids Following Surgery
A pain-management protocol designed by Emese Zsiros, MD, PhD, FACOG, to be reported at the American Society of Clinical Oncology 2021 annual meeting, resulted in a 45% decrease in opioids prescribed to patients undergoing surgery, without...
4-Jun-2021 9:00 PM EDT Add to Favorites
See All News
25-Jan-2017 10:05 AM EST
Dr. Igor Puzanov of @RoswellPark Cancer Institute Avail. To Comment on Chan/Zuckerberg $30b Pledge for #Medicalresearch
22-Sep-2016 3:05 PM EDT
Roswell Park's Dr. James Marshall Available to Interpret, Comment on Who Statement on Processed Meats and Cancer Risk
27-Oct-2015 5:05 PM EDT
Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT